# RNA pathway scoring

Source: https://onco.cc/terms/rna-pathway-scoring/  
OnCo record `rna-pathway-scoring` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A pathway score summarises selected gene messages under a defined method and comparison scale.

## Summary

Inputs are expression data, a gene set and scoring rules; shared genes make pathway scores related; two numbers called pathway score are not necessarily comparable.

## Fields

- Kind: Term
- Last checked: 2026-11-10

## Notes

- Inputs are expression data, a gene set and scoring rules; shared genes make pathway scores related; two numbers called pathway score are not necessarily comparable.
- ssGSEA compares rank distributions inside and outside a set within a sample, with optional scaling that can involve the supplied score collection; GSVA estimates each gene's distribution across supplied samples first, so changing the cohort changes the comparison; the GSVA package also implements ssGSEA.
- A score is commonly unitless and is not automatically a significance test or probability; a percentile ranks against a defined group, so the 90th percentile is not 90% activity.
- RNA scores do not directly measure protein, phosphorylation, flux or dependence; feedback can raise messages while output falls; a response classifier needs its own locked model.
- Fictional teaching exercise: Ranks A to E, set {A,C,E}: mean rank (1+3+5)/3=3; a teaching calculation, neither ssGSEA nor GSVA, and not an activity measure.
- The original GSEA framework evaluated ranked expression evidence in cohort comparisons; its output is not interchangeable with every per-sample score.
- Scoring existing RNA requires no additional tissue; functional tests may. Record gene IDs/set version, measured universe, input scale, parameters, algorithm and reference cohort. Report unitless scores, normalised scores or percentiles explicitly. Runtime and filters vary; replication and sensitivity to mixtures/missing genes test robustness. Overlapping sets, platform/composition shifts and changed cohorts constrain comparisons; activation and clinical cutoffs need separate validation.

## Sources

- Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.: https://pubmed.ncbi.nlm.nih.gov/16199517/
- GSVA: gene set variation analysis for microarray and RNA-seq data.: https://pubmed.ncbi.nlm.nih.gov/23323831/
- GSVA software vignette: https://bioconductor.org/packages/release/bioc/vignettes/GSVA/inst/doc/GSVA.html

## Connected records

- terms: [Bulk RNA sequencing (RNA-seq) and the full transcriptome](https://onco.cc/terms/bulk-rna-seq/)

---
JSON: https://onco.cc/api/v1/entities/rna-pathway-scoring.json